FMA
ALBO

FNY Managed Accounts’s Albireo Pharma Inc ALBO Stock Holding History

FNY Managed Accounts’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-333
Closed -$4.4K – 408
2015
Q3 		$4.4K Sell
333
-667
-67% -$16.8K 0.01% 321
2015
Q2 		$30.9K Sell
1,000
-4,500
-82% -$151K 0.04% 183
2015
Q1 		$196K Sell
5,500
-5,067
-48% -$214K 0.16% 80
2014
Q4 		$422K Buy
10,567
+9,500
+890% +$417K 0.5% 29
2014
Q3 		$53.4K Buy
+1,067
New +$61.3K 0.16% 86

Other funds holding ALBO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FNY Managed Accounts's ALBO Position: Q4 2015 in Review

FNY Managed Accounts sold out of Albireo Pharma Inc (ALBO) in Q4 2015, closing a stake of 333 shares — an estimated $4.4K sold.

FNY Managed Accounts first reported a position in ALBO in Q3 2014 and held it in 5 quarters. The position peaked at $422K in Q4 2014. 33 funds tracked by Wall St. Rank hold ALBO as of Q4 2015.

  • FNY Managed Accounts reported no remaining Albireo Pharma Inc position as of Q4 2015 after selling out during the quarter.
  • FNY Managed Accounts sold 333 Albireo Pharma Inc shares in Q4 2015, an estimated $4.4K.
  • FNY Managed Accounts first reported a position in Albireo Pharma Inc in Q3 2014 and held it in 5 quarters.
  • FNY Managed Accounts's Albireo Pharma Inc position peaked at $422K in Q4 2014.
  • 33 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2015.

Based on FNY Managed Accounts's 13F filing for Q4 2015, filed 25 Jan 2016.